AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Anika Therapeutics granted non-statutory stock options covering 2,500 shares of common stock to a newly hired non-executive employee at a per share exercise price of $9.15. The grant was made under the Anika Therapeutics, Inc. 2021 Inducement Plan and was approved by the compensation committee of the board of directors. The grant was a material inducement to the employee's acceptance of employment.
Anika Therapeutics, Inc. (NASDAQ: ANIK), a leading player in osteoarthritis pain management and regenerative solutions, has granted non-statutory stock options to a newly hired non-executive employee. The grant, made on September 2, 2025, covers 2,500 shares of common stock at a per share exercise price of $9.15. The grant was executed under the Anika Therapeutics, Inc. 2021 Inducement Plan and was approved by the compensation committee of the board of directors. This move was a material inducement to the employee's acceptance of employment with Anika.Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet